Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2016, Article ID 8514056, 9 pages
http://dx.doi.org/10.1155/2016/8514056
Review Article

Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression

1Department of Oriental Medicine Resources, Mokpo National University, Muan-gun, Jeonnam 534-729, Republic of Korea
2College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Muan-gun, Jeonnam 58554, Republic of Korea

Received 30 December 2015; Revised 13 February 2016; Accepted 15 February 2016

Academic Editor: Mark Segal

Copyright © 2016 Keshav Raj Paudel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. VanWijk, E. VanBavel, A. Sturk, and R. Nieuwland, “Microparticles in cardiovascular diseases,” Cardiovascular Research, vol. 59, no. 2, pp. 277–287, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. C. N. Franca, M. C. de Oliveira Izar, J. B. do Amaral, D. M. Tegani, and F. A. H. Fonseca, “Microparticles as potential biomarkers of cardiovascular disease,” Arquivos Brasileiros de Cardiologia, vol. 104, no. 2, pp. 169–174, 2015. View at Google Scholar
  3. A. Angelillo-Scherrer, “Leukocyte-derived microparticles in vascular homeostasis,” Circulation Research, vol. 110, no. 2, pp. 356–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Patz, C. Trattnig, G. Grünbacher et al., “More than cell dust: microparticles isolated from cerebrospinal fluid of brain injured patients are messengers carrying mRNAs, miRNAs, and proteins,” Journal of Neurotrauma, vol. 30, no. 14, pp. 1232–1242, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Pasterkamp and D. de Kleijn, “Microparticles, debris that hurts,” Journal of the American College of Cardiology, vol. 52, no. 16, pp. 1312–1313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. E. Connor, T. Exner, D. D. F. Ma, and J. E. Joseph, “The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib,” Thrombosis and Haemostasis, vol. 103, no. 5, pp. 1044–1052, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Sekuła, G. Janawa, E. Stankiewicz, and E. Stepień, “Endothelial microparticle formation in moderate concentrations of homocysteine and methionine in vitro,” Cellular and Molecular Biology Letters, vol. 16, no. 1, pp. 69–78, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. G. Macey, N. Enniks, and S. Bevan, “Flow cytometric analysis of microparticle phenotype and their role in thrombin generation,” Cytometry Part B: Clinical Cytometry, vol. 80, no. 1, pp. 57–63, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Amabile, A. P. Guérin, A. Leroyer et al., “Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure,” Journal of the American Society of Nephrology, vol. 16, no. 11, pp. 3381–3388, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. A. F. Tramontano, R. Lyubarova, J. Tsiakos, T. Palaia, J. R. Deleon, and L. Ragolia, “Circulating endothelial microparticles in diabetes mellitus,” Mediators of Inflammation, vol. 2010, Article ID 250476, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C.-C. Wang, C.-C. Tseng, C.-C. Hsiao et al., “Circulating endothelial-derived activated microparticle: a useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung cancer,” BioMed Research International, vol. 2014, Article ID 173401, 11 pages, 2014. View at Publisher · View at Google Scholar
  12. C.-C. Tseng, C.-C. Wang, H.-C. Chang et al., “Levels of circulating microparticles in lung cancer patients and possible prognostic value,” Disease Markers, vol. 35, no. 5, pp. 301–310, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. S. M. Schindler, J. P. Little, and A. Klegeris, “Microparticles: a new perspective in central nervous system disorders,” BioMed Research International, vol. 2014, Article ID 756327, 17 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. M. Babbitt, K. M. Diaz, D. L. Feairheller et al., “Endothelial activation microparticles and inflammation status improve with exercise training in African Americans,” International Journal of Hypertension, vol. 2013, Article ID 538017, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. R. V. Vince, B. Chrismas, A. W. Midgley, L. R. McNaughton, and L. A. Madden, “Hypoxia mediated release of endothelial microparticles and increased association of S100A12 with circulating neutrophils,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 1, pp. 2–6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Perez-Hernandez and R. Cortes, “Extracellular vesicles as biomarkers of systemic lupus erythematosus,” Disease Markers, vol. 2015, Article ID 613536, 7 pages, 2015. View at Publisher · View at Google Scholar
  17. A. Celi, R. Lorenzet, B. C. Furie, and B. Furie, “Microparticles and a P-selectin-mediated pathway of blood coagulation,” Disease Markers, vol. 20, no. 6, pp. 347–352, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. S. F. Mause and C. Weber, “Microparticles: protagonists of a novel communication network for intercellular information exchange,” Circulation Research, vol. 107, no. 9, pp. 1047–1057, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Toth, S. Liebhardt, K. Steinig et al., “Platelet-derived microparticles and coagulation activation in breast cancer patients,” Thrombosis and Haemostasis, vol. 100, no. 4, pp. 663–669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. S. Williams, H. L. Rogers, N.-Y. Wang, and R. C. Ziegelstein, “Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome?” Psychosomatics, vol. 55, no. 3, pp. 252–260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Mezouar, D. Mege, R. Darbousset et al., “Involvement of platelet-derived microparticles in tumor progression and thrombosis,” Seminars in Oncology, vol. 41, no. 3, pp. 346–358, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Faure, L. Dou, F. Sabatier et al., “Elevation of circulating endothelial microparticles in patients with chronic renal failure,” Journal of Thrombosis and Haemostasis, vol. 4, no. 3, pp. 566–573, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Tual-Chalot, F. Gagnadoux, W. Trzepizur, P. Priou, R. Andriantsitohaina, and M. C. Martinez, “Circulating microparticles from obstructive sleep apnea syndrome patients induce endothelin-mediated angiogenesis,” Biochimica et Biophysica Acta, vol. 1842, no. 2, pp. 202–207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Cheng, Y. Wang, J. Li et al., “Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans,” International Journal of Cardiology, vol. 167, no. 3, pp. 936–942, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Wen, V. Combes, A. Bonhoure, B. B. Weksler, P.-O. Couraud, and G. E. R. Grau, “Endotoxin-induced monocytic microparticles have contrasting effects on endothelial inflammatory responses,” PLoS ONE, vol. 9, no. 3, Article ID e91597, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Nieuwland, R. J. Berckmans, S. McGregor et al., “Cellular origin and procoagulant properties of microparticles in meningococcal sepsis,” Blood, vol. 95, no. 3, pp. 930–935, 2000. View at Google Scholar · View at Scopus
  27. F. F. Hoyer, M. K. Giesen, C. Nunes França, D. Lütjohann, G. Nickenig, and N. Werner, “Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice,” Journal of Cellular and Molecular Medicine, vol. 16, no. 11, pp. 2777–2788, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. O. P. Barry, M. G. Kazanietz, D. Praticò, and G. A. FitzGerald, “Arachidonic acid in platelet microparticles up-regulates cyclooxygenase- 2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway,” Journal of Biological Chemistry, vol. 274, no. 11, pp. 7545–7556, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. O. P. Barry, D. Praticò, J. A. Lawson, and G. A. FitzGerald, “Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles,” Journal of Clinical Investigation, vol. 99, no. 9, pp. 2118–2127, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. O. P. Barry, D. Praticò, R. C. Savani, and G. A. FitzGerald, “Modulation of monocyte-endothelial cell interactions by platelet microparticles,” Journal of Clinical Investigation, vol. 102, no. 1, pp. 136–144, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. S. B. Forlow, R. P. McEver, and M. U. Nollert, “Leukocyte-leukocyte interactions mediated by platelet microparticles under flow,” Blood, vol. 95, no. 4, pp. 1317–1323, 2000. View at Google Scholar · View at Scopus
  32. W. Jy, W.-W. Mao, L. L. Horstman, J. Tao, and Y. S. Ahn, “Platelet microparticles bind, activate and aggregate neutrophils in vitro,” Blood Cells, Molecules, and Diseases, vol. 21, no. 3, pp. 217–231, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. J. J. Jimenez, W. Jy, L. M. Mauro, L. L. Horstman, C. Soderland, and Y. S. Ahn, “Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation,” British Journal of Haematology, vol. 123, no. 5, pp. 896–902, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Koga, S. Sugiyama, K. Kugiyama et al., “Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease,” Journal of the American College of Cardiology, vol. 45, no. 10, pp. 1622–1630, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Szotowski, S. Antoniak, P. Goldin-Lang et al., “Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells,” Cardiovascular Research, vol. 73, no. 4, pp. 806–812, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. T. P. Lozito and R. S. Tuan, “Endothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascular matrix remodeling,” Journal of Cellular Physiology, vol. 227, no. 2, pp. 534–549, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. M. Curtis, P. F. Wilkinson, M. Gui, T. L. Gales, E. Hu, and J. M. Edelberg, “p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles,” Journal of Thrombosis and Haemostasis, vol. 7, no. 4, pp. 701–709, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Mallat, H. Benamer, B. Hugel et al., “Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes,” Circulation, vol. 101, no. 8, pp. 841–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. J. J. Jimenez, W. Jy, L. M. Mauro, C. Soderland, L. L. Horstman, and Y. S. Ahn, “Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis,” Thrombosis Research, vol. 109, no. 4, pp. 175–180, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Gauley and D. S. Pisetsky, “The release of microparticles by RAW 264.7 macrophage cells stimulated with TLR ligands,” Journal of Leukocyte Biology, vol. 87, no. 6, pp. 1115–1123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Li, D. Yu, K. Jon Williams, and M.-L. Liu, “Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 9, pp. 1818–1824, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. J.-G. Wang, J. C. Williams, B. K. Davis et al., “Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner,” Blood, vol. 118, no. 8, pp. 2366–2374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Milbank, R. Soleti, E. Martinez et al., “Microparticles from apoptotic RAW 264.7 macrophage cells carry tumour necrosis factor-α functionally active on cardiomyocytes from adult mice,” Journal of Extracellular Vesicles, vol. 4, article 28621, 2015. View at Google Scholar
  44. C. Bardelli, A. Amoruso, D. Federici Canova et al., “Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands,” British Journal of Pharmacology, vol. 165, no. 3, pp. 716–728, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. C. M. Boulanger, A. Scoazec, T. Ebrahimian et al., “Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction,” Circulation, vol. 104, no. 22, pp. 2649–2652, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. Z. Mallat, B. Hugel, J. Ohan, G. Lesèche, J.-M. Freyssinet, and A. Tedgui, “Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity,” Circulation, vol. 99, no. 3, pp. 348–353, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Hristov, W. Erl, S. Linder, and P. C. Weber, “Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro,” Blood, vol. 104, no. 9, pp. 2761–2766, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Dignat-George and C. M. Boulanger, “The many faces of endothelial microparticles,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 1, pp. 27–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Mezentsev, R. M. H. Merks, E. O'Riordan et al., “Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 3, pp. H1106–H1114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Bretelle, F. Sabatier, D. Desprez et al., “Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction,” Thrombosis and Haemostasis, vol. 89, no. 3, pp. 486–492, 2003. View at Google Scholar · View at Scopus
  51. R. A. Preston, W. Jy, J. J. Jimenez et al., “Effects of severe hypertension on endothelial and platelet microparticles,” Hypertension, vol. 41, no. 2, pp. 211–217, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. M. J. VanWijk, K. Boer, R. J. Berckmans et al., “Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents,” Thrombosis and Haemostasis, vol. 88, no. 3, pp. 415–420, 2002. View at Google Scholar · View at Scopus
  53. M. J. VanWijk, R. Nieuwland, K. Boer, J. A. M. Van Der Post, E. VanBavel, and A. Sturk, “Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction?” American Journal of Obstetrics & Gynecology, vol. 187, no. 2, pp. 450–456, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. H.-H. Lee, K. R. Paudel, and D.-W. Kim, “Terminalia chebula fructus inhibits migration and proliferation of vascular smooth muscle cells and production of inflammatory mediators in RAW 264.7,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 502182, 10 pages, 2015. View at Publisher · View at Google Scholar
  55. R. Karki, S.-B. Kim, and D.-W. Kim, “Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation,” Experimental Cell Research, vol. 319, no. 20, pp. 3238–3250, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Karki, C.-H. Park, and D.-W. Kim, “Extract of buckwheat sprouts scavenges oxidation and inhibits pro-inflammatory mediators in lipopolysaccharide-stimulated macrophages (RAW264.7),” Journal of Chinese Integrative Medicine, vol. 11, no. 4, pp. 246–252, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Karki, N. Sahi, E.-R. Jeon, Y.-S. Park, and D.-W. Kim, “Chungtaejeon, a Korean fermented tea, scavenges oxidation and inhibits cytokine induced proliferation and migration of human aortic smooth muscle cells,” Plant Foods for Human Nutrition, vol. 66, no. 1, pp. 27–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Karki, E.-R. Jeon, and D.-W. Kim, “Nelumbo nucifera leaf extract inhibits neointimal hyperplasia through modulation of smooth muscle cell proliferation and migration,” Nutrition, vol. 29, no. 1, pp. 268–275, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Karki, O.-M. Ho, and D.-W. Kim, “Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-κB activation in vascular smooth muscle cells,” Biochimica et Biophysica Acta, vol. 1830, no. 3, pp. 2619–2628, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. G. Taraboletti, S. D'Ascenzo, P. Borsotti, R. Giavazzi, A. Pavan, and V. Dolo, “Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells,” The American Journal of Pathology, vol. 160, no. 2, pp. 673–680, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. H. C. Anderson, “Matrix vesicles and calcification,” Current Rheumatology Reports, vol. 5, no. 3, pp. 222–226, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Lacroix, F. Sabatier, A. Mialhe et al., “Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro,” Blood, vol. 110, no. 7, pp. 2432–2439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. O. Morel, N. Morel, B. Hugel et al., “The significance of circulating microparticles in physiology, inflamatory and thrombotic diseases,” La Revue de Médecine Interne, vol. 26, no. 10, pp. 791–801, 2005 (French). View at Publisher · View at Google Scholar · View at Scopus
  64. A. H. M. Moons, M. Levi, and R. J. G. Peters, “Tissue factor and coronary artery disease,” Cardiovascular Research, vol. 53, no. 2, pp. 313–325, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Steffel, M. Hermann, H. Greutert et al., “Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation,” Circulation, vol. 111, no. 13, pp. 1685–1689, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Napoleone, A. Di Santo, and R. Lorenzet, “Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk,” Blood, vol. 89, no. 2, pp. 541–549, 1997. View at Google Scholar · View at Scopus
  67. M. Mesri and D. C. Altieri, “Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway,” Journal of Biological Chemistry, vol. 274, no. 33, pp. 23111–23118, 1999. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Tesse, M. C. Martínez, B. Hugel et al., “Upregulation of proinflammatory proteins through NF-κB pathway by shed membrane microparticles results in vascular hyporeactivity,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 12, pp. 2522–2527, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Scanu, N. Molnarfi, K. J. Brandt, L. Gruaz, J.-M. Dayer, and D. Burger, “Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins,” Journal of Leukocyte Biology, vol. 83, no. 4, pp. 921–927, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. M. H. Gräler and E. J. Goetzl, “Lysophospholipids and their G protein-coupled receptors in inflammation and immunity,” Biochimica et Biophysica Acta, vol. 1582, no. 1–3, pp. 168–174, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. A. S. Leroyer, F. Anfosso, R. Lacroix et al., “Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis,” Thrombosis and Haemostasis, vol. 104, no. 3, pp. 456–463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Simoncini, M.-S. Njock, S. Robert et al., “Trail/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: a potential mechanism linking inflammation and coagulation,” Circulation Research, vol. 104, no. 8, pp. 943–951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. F. Meziani, A. Tesse, E. David et al., “Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility,” The American Journal of Pathology, vol. 169, no. 4, pp. 1473–1483, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Mesri and D. C. Altieri, “Endothelial cell activation by leukocyte microparticles,” Journal of Immunology, vol. 161, no. 8, pp. 4382–4387, 1998. View at Google Scholar · View at Scopus
  75. S. H. van Ierssel, E. M. van Craenenbroeck, V. M. Conraads et al., “Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied,” Thrombosis Research, vol. 125, no. 4, pp. 332–339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. P. J. A. Yong, C. H. Koh, and W. S. N. Shim, “Endothelial microparticles: missing link in endothelial dysfunction?” European Journal of Preventive Cardiology, vol. 20, no. 3, pp. 496–512, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. R. Soleti, T. Benameur, C. Porro, M. A. Panaro, R. Andriantsitohaina, and M. C. Martínez, “Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors,” Carcinogenesis, vol. 30, no. 4, pp. 580–588, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. P. E. Rautou, A. S. Leroyer, B. Ramkhelawon et al., “Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration,” Circulation Research, vol. 108, no. 3, pp. 335–343, 2011. View at Publisher · View at Google Scholar
  79. K. D. O'Brien, T. O. McDonald, A. Chait, M. D. Allen, and C. E. Alpers, “Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content,” Circulation, vol. 93, no. 4, pp. 672–682, 1996. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Virmani, F. D. Kolodgie, A. P. Burke et al., “Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 10, pp. 2054–2061, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. P. R. Moreno, K.-R. Purushothaman, M. Sirol, A. P. Levy, and V. Fuster, “Neovascularization in human atherosclerosis,” Circulation, vol. 113, no. 18, pp. 2245–2252, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Jayachandran, R. D. Litwiller, W. G. Owen, and V. M. Miller, “Circulating microparticles and endogenous estrogen in newly menopausal women,” Climacteric, vol. 12, no. 2, pp. 177–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. N. Figueroa-Vega, C. Moreno-Frías, and J. M. Malacara, “Alterations in adhesion molecules, pro-inflammatory cytokines and cell-derived microparticles contribute to intima-media thickness and symptoms in postmenopausal women,” PLoS ONE, vol. 10, no. 5, Article ID e0120990, 2015. View at Publisher · View at Google Scholar
  84. M. Jayachandran, R. D. Litwiller, B. D. Lahr et al., “Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk,” Journal of Cardiovascular Translational Research, vol. 4, no. 6, pp. 811–822, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. M.-V. Noci, R. Ramírez, M. Lluch, M. Rodríguez, and J. Carracedo, “Changes in endothelial microparticles and endothelial progenitor cells in obese patients in response to surgical stress,” The Journal of Bone & Joint Surgery—American Volume, vol. 97, no. 5, pp. 353–358, 2015. View at Publisher · View at Google Scholar
  86. L. F. Heinrich, D. K. Andersen, M. E. Cleasby, and C. Lawson, “Long-term high fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells,” British Journal of Nutrition, vol. 113, no. 11, pp. 1704–1711, 2015. View at Publisher · View at Google Scholar